Brief: China Regenerative Medicine International Says Co Unlikely To Publish 2021 Audited Annual Results On Or Before 31 Mar
25/03/2022 15:35
March 25 (Reuters) - China Regenerative Medicine
International Ltd 8158.HK :
* CHINA REGENERATIVE MEDICINE INTERNATIONAL LTD - CO
UNLIKELY TO
PUBLISH 2021 AUDITED ANNUAL RESULTS ON OR BEFORE 31 MAR
* CHINA REGENERATIVE MEDICINE INTERNATIONAL LTD - 2021
ANNUAL
RESULTS EXPECTED TO BE PUBLISHED BY END OF APRIL 2022
Source text for Eikon: ID:
Further company coverage: 8158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital